Pleural effusions are a big problem if you have mesothelioma. Pleural effusion is the medical term for excess fluid in the space between the inner and outer linings of your lungs. Mesothelioma causes this excess fluid. The excess fluid is bad because it makes it harder for you to breathe. It also adds to your
Category Archives: News
Your doctor wants to be able to give you an accurate prognosis for survival after you’re diagnosed with or treated for mesothelioma. There are a number of approaches doctors can use for making mesothelioma prognoses. Some of these approaches are more accurate than others. But all are pretty good. The problem is that most of
The best strategy for treating diffuse malignant peritoneal mesothelioma is a combination of cytoreductive surgery and HIPEC (hyperthermic intraperitoneal chemotherapy). That’s what French researchers writing in the European Journal of Cancer believe after examining 23 years worth of medical records from patients with diffuse malignant peritoneal mesothelioma. You should therefore feel more confident about cytoreductive
The manufacturer of tazemetostat has now formally begun its planned Phase 2 clinical trial of this novel targeted mesothelioma therapeutic. Tazemetostat is reported to be capable of inhibiting EZH2 activity. Epizyme, Inc., based in Cambridge, Massachusetts, announced in mid-August 2016 that the first of an expected 67 patients began receiving tazemetostat. Tazemetostat is designed to
Your doctor has some good advice for you. Never stop taking your mesothelioma medicines. You want to live long? Then keep taking those medicines. Yet many mesothelioma patients do just the opposite. They stop taking their medicines. Or they get lazy and take them only occasionally. Or they simply forget. This has a name. It’s
Consider yourself fortunate if you don’t have mesothelioma despite exposure to asbestos at some point in your past. But your good fortune might not hold if you currently have Crohn’s disease. Researchers think Crohn’s disease with transmural inflammation may be a precursor of malignant peritoneal mesothelioma. Crohn’s disease is a chronic inflammatory condition that affects
There are three ways to treat mesothelioma in a clinic setting — surgery, chemotherapy and radiation. They can be used as standalone therapies or in combination. But those three are basically the only choices. For the moment, at least. Scientists around the world have been busy developing and testing what are called novel molecular therapies for
Another potential target for treating mesothelioma has been identified. It’s the plasma membrane receptor P2X7R. A team of researchers from the University of Ferrara in Italy are reporting that it may be possible to stop mesothelioma by blocking P2X7R. In the online edition of the journal Oncotarget, the researchers said they found P2X7R receptors present
Elderly patients sometimes hear about the benefits of mesothelioma surgery and then ignore it. They think surgery isn’t for them because they’re old to go under the knife. Or they think an operation would be pointless at their advanced age. Or they fear their bodies are too frail to bear up under the physical demands
One of the first things you want to know when you’re diagnosed with mesothelioma is the prognosis — what to expect in the fight to come. The problem is that mesothelioma is a treacherous cancer. So much so that the course it will run can be difficult to predict. Researchers around the world have been studying
